AC
COLL icon

AXQ Capital’s Collegium Pharmaceutical COLL Stock Holding History

AXQ Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
5,829
-12,147
-68% -$415K 0.02% 711
2026
Q1 		$594K Buy
+17,976
New +$761K 0.08% 361

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

AXQ Capital's COLL Position: Q2 2026 in Review

AXQ Capital reduced its Collegium Pharmaceutical (COLL) stake by 68% in Q2 2026, selling an estimated $415K and leaving 5,829 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #711.

AXQ Capital first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. The position peaked at $594K in Q1 2026. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • AXQ Capital held 5,829 shares of Collegium Pharmaceutical worth $211K as of Q2 2026.
  • AXQ Capital sold 12,147 Collegium Pharmaceutical shares in Q2 2026, an estimated $415K.
  • Collegium Pharmaceutical made up 0.02% of AXQ Capital's portfolio in Q2 2026, its #711 holding.
  • AXQ Capital first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • AXQ Capital's Collegium Pharmaceutical position peaked at $594K in Q1 2026.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.